Cardiac Output Monitoring Devices Market size is projected to surpass USD 2 Billion by the end of 2033, growing at a CAGR of 4% during the forecast period i.e., 2023-2033. In the year 2022, the industry size of cardiac output monitoring devices was over USD 1 Billion.The growth of the market can be attributed to the worldwide surging occurrences of cardiovascular diseases (CVDs), along with the rising awareness among people regarding CVD diseases. As per the data released by the World Health Organization (WHO), 17.9 million people worldwide die from CVDs each year, contributing to 32% of all mortalities. Besides this, growth in the healthcare sector is also a significant factor that is projected to further fuel the global cardiac output monitoring devices market growth over the forecast period.
In addition to these, factors that are believed to fuel the market growth of cardiac output monitoring devices include the rise in cardiac arrest cases throughout the world. For instance, in the United States, more than 358,000 cardiac arrests occur outside of hospitals every year, with approximately 7 in 10 occurring at home. Thus, the count of patients admitted to critical care units for intensive or invasive monitoring has been increasing. As a result, cardiac output monitoring devices have become a vital element in assessing patients in the operating room, critical care unit, and other places. Additionally, a significant surge in respiratory problems, a rise in various types of severe infections, as well as a rise in the count of unmet medical requirements in emerging nations are some more factors that are anticipated to accelerate the market trend over the projected time frame.
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~4% |
|
Base Year Market Size (2022) |
~ USD 1 Billion |
|
Forecast Year Market Size (2033) |
~ USD 2 Billion |
|
Regional Scope |
|
Type (Invasive, Non-Invasive)
The global cardiac output monitoring devices market is segmented and analyzed for demand and supply by type into invasive and non-invasive. Out of these two segments, the invasive segment held a market share of 58% in the year 2022 and is estimated to garner further growth over the projected time frame. The growth of the segment can be attributed to the increasing count of cardiac implant surgeries across the globe. In addition to this, the growing popularity of minimally invasive techniques involving arterial and venous lines is also anticipated to augment segment growth during the forecast period. For instance, every year, in the United States, nearly 400,000 coronary artery bypass grafting (CABG) surgeries are performed.
End-user (Hospitals, Ambulatory Surgical Centers)
The global cardiac output monitoring devices market is also segmented and analyzed for demand and supply by end-user into hospitals, and ambulatory surgical centers. Amongst these two segments, the hospital segment is expected to garner a significant share. The growth of the segment can be ascribed to the upsurge in the count of hospitals, followed by the escalating number of patient visits to be diagnosed in hospitals throughout the world. For instance, there were over 8,359 hospitals in Japan as of 2020. Whereas Korea had about 4,110 hospitals. Moreover, the availability of favorable medical reimbursement, and surge in the cardiac implant procedures throughout the world are also anticipated to further create numerous opportunities for the growth of the segment in the coming years.
Our in-depth analysis of the global market includes the following segments:
|
By Product |
|
|
By Type |
|
|
By Technology |
|
|
By End-User |
|
North American Market Forecast
The North American cardiac output monitoring devices market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the increasing frequency of heart diseases, and coronary artery disease in the region. As per the data provided by the Centers for Disease Control and Prevention, in the United States, heart disease accounted for the deaths of about 697,000 people in 2020. Furthermore, coronary artery disease affects nearly 20.1 million adults aged 20 and above. In addition, rising healthcare expenditure and accessibility of technologically advanced equipment are also anticipated to boost the market growth further during the forecast period in the region.
APAC Market Statistics
Furthermore, the Asia Pacific cardiac output monitoring devices market is also projected to display notable market growth by the end of 2033. The growth of the market can be attributed to the escalating prevalence of CVDs, along with the growth in the healthcare infrastructure in the region. For instance, in 2019, CVDs were the major factor responsible for death in Asia, accounting for approximately 11 million deaths in the region. Moreover, surging awareness among people about the CVDs and their treatment is another significant factor that is anticipated to push the market growth further over the projected time frame in the APAC region.
ICU Medical Inc. acquired Smiths Medical from Smiths Group Plc. In addition to syringes and ambulatory infusion devices, Smith Medical also produces vascular access products and vital care products.
Schwarzer Cardiotek GmbH received 510(k) clearance from the US Food and Drug Administration for version 2.2 of its EP-TRACER electronic physiological measurement system, designed to provide a high-quality display of intracardiac ECG signals.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?